123 related articles for article (PubMed ID: 31363818)
1. Measurement of urinary arsenic profiles and DNA hypomethylation in a case-control study of urothelial carcinoma.
Chung CJ; Lee HL; Chang CH; Chang H; Liu CS; Jung WT; Liu HJ; Liou SH; Chung MC; Hsueh YM
Arch Toxicol; 2019 Aug; 93(8):2155-2164. PubMed ID: 31363818
[TBL] [Abstract][Full Text] [Related]
2. Plasma folate level, urinary arsenic methylation profiles, and urothelial carcinoma susceptibility.
Huang YK; Pu YS; Chung CJ; Shiue HS; Yang MH; Chen CJ; Hsueh YM
Food Chem Toxicol; 2008 Mar; 46(3):929-38. PubMed ID: 18054417
[TBL] [Abstract][Full Text] [Related]
3. XRCC1 Arg194Trp and Arg399Gln polymorphisms and arsenic methylation capacity are associated with urothelial carcinoma.
Chiang CI; Huang YL; Chen WJ; Shiue HS; Huang CY; Pu YS; Lin YC; Hsueh YM
Toxicol Appl Pharmacol; 2014 Sep; 279(3):373-379. PubMed ID: 25018058
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of human 8-oxoguanine DNA glycosylase 1 and 8-hydroxydeoxyguanosine increase susceptibility to arsenic methylation capacity-related urothelial carcinoma.
Huang CY; Pu YS; Shiue HS; Chen WJ; Lin YC; Hsueh YM
Arch Toxicol; 2016 Aug; 90(8):1917-27. PubMed ID: 26359225
[TBL] [Abstract][Full Text] [Related]
5. Urinary total arsenic and 8-hydroxydeoxyguanosine are associated with renal cell carcinoma in an area without obvious arsenic exposure.
Huang CY; Su CT; Chung CJ; Pu YS; Chu JS; Yang HY; Wu CC; Hsueh YM
Toxicol Appl Pharmacol; 2012 Aug; 262(3):349-54. PubMed ID: 22659136
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of plasma alpha-tocopherols on the risk of inorganic arsenic-related urothelial carcinoma.
Chung CJ; Pu YS; Chen YT; Su CT; Wu CC; Shiue HS; Huang CY; Hsueh YM
Sci Total Environ; 2011 Feb; 409(6):1039-45. PubMed ID: 21227482
[TBL] [Abstract][Full Text] [Related]
7. Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area.
Chung CJ; Huang CJ; Pu YS; Su CT; Huang YK; Chen YT; Hsueh YM
Toxicol Appl Pharmacol; 2008 Jan; 226(1):14-21. PubMed ID: 17950770
[TBL] [Abstract][Full Text] [Related]
8. Determination of potential sources of heavy metals in patients with urothelial carcinoma in central Taiwan: a biomonitoring case-control study.
Chung CJ; Lee HL; Chang CH; Wu CD; Liu CS; Chung MC; Hsu HT
Environ Geochem Health; 2023 Jul; 45(7):5401-5414. PubMed ID: 36705787
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma.
Chung CJ; Huang CJ; Pu YS; Su CT; Huang YK; Chen YT; Hsueh YM
Toxicol Appl Pharmacol; 2008 Oct; 232(2):203-9. PubMed ID: 18640142
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of inflammatory genes and arsenic methylation capacity are associated with urothelial carcinoma.
Wu CC; Huang YK; Chung CJ; Huang CY; Pu YS; Shiue HS; Lai LA; Lin YC; Su CT; Hsueh YM
Toxicol Appl Pharmacol; 2013 Oct; 272(1):30-6. PubMed ID: 23727622
[TBL] [Abstract][Full Text] [Related]
11. Gene polymorphisms of glutathione S-transferase omega 1 and 2, urinary arsenic methylation profile and urothelial carcinoma.
Chung CJ; Pu YS; Su CT; Huang CY; Hsueh YM
Sci Total Environ; 2011 Jan; 409(3):465-70. PubMed ID: 21094982
[TBL] [Abstract][Full Text] [Related]
12. Comparison of genome-wide DNA methylation in urothelial carcinomas of patients with and without arsenic exposure.
Yang TY; Hsu LI; Chiu AW; Pu YS; Wang SH; Liao YT; Wu MM; Wang YH; Chang CH; Lee TC; Chen CJ
Environ Res; 2014 Jan; 128():57-63. PubMed ID: 24268366
[TBL] [Abstract][Full Text] [Related]
13. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure.
Pu YS; Yang SM; Huang YK; Chung CJ; Huang SK; Chiu AW; Yang MH; Chen CJ; Hsueh YM
Toxicol Appl Pharmacol; 2007 Jan; 218(2):99-106. PubMed ID: 17196235
[TBL] [Abstract][Full Text] [Related]
14. Relationships among DNA hypomethylation, Cd, and Pb exposure and risk of cigarette smoking-related urothelial carcinoma.
Chung CJ; Chang CH; Liou SH; Liu CS; Liu HJ; Hsu LC; Chen JS; Lee HL
Toxicol Appl Pharmacol; 2017 Feb; 316():107-113. PubMed ID: 28025111
[TBL] [Abstract][Full Text] [Related]
15. Environmental tobacco smoke and arsenic methylation capacity are associated with urothelial carcinoma.
Wu CC; Chen MC; Huang YK; Huang CY; Lai LA; Chung CJ; Shiue HS; Pu YS; Lin YC; Han BC; Wang YH; Hsueh YM
J Formos Med Assoc; 2013 Sep; 112(9):554-60. PubMed ID: 23871550
[TBL] [Abstract][Full Text] [Related]
16. The effect of cigarette smoke and arsenic exposure on urothelial carcinoma risk is modified by glutathione S-transferase M1 gene null genotype.
Chung CJ; Huang CY; Pu YS; Shiue HS; Su CT; Hsueh YM
Toxicol Appl Pharmacol; 2013 Jan; 266(2):254-9. PubMed ID: 23159782
[TBL] [Abstract][Full Text] [Related]
17. Comparison of arsenic methylation capacity and polymorphisms of arsenic methylation genes between bladder cancer and upper tract urothelial carcinoma.
Huang CY; Lin YC; Shiue HS; Chen WJ; Su CT; Pu YS; Ao PL; Hsueh YM
Toxicol Lett; 2018 Oct; 295():64-73. PubMed ID: 29859237
[TBL] [Abstract][Full Text] [Related]
18. Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study.
Huang YK; Huang YL; Hsueh YM; Yang MH; Wu MM; Chen SY; Hsu LI; Chen CJ
Cancer Causes Control; 2008 Oct; 19(8):829-39. PubMed ID: 18351295
[TBL] [Abstract][Full Text] [Related]
19. Urinary 8-Hydroxy-2'-Deoxyguanosine Levels and Cardiovascular Disease Incidence in Japan.
Nagao M; Kobashi G; Umesawa M; Cui R; Yamagishi K; Imano H; Okada T; Kiyama M; Kitamura A; Sairenchi T; Haruyama Y; Ohira T; Iso H;
J Atheroscler Thromb; 2020 Oct; 27(10):1086-1096. PubMed ID: 32161250
[TBL] [Abstract][Full Text] [Related]
20. The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma.
Hsueh YM; Lin YC; Chen WJ; Huang CY; Shiue HS; Pu YS; Chen CH; Su CT
Toxicol Appl Pharmacol; 2017 Oct; 332():1-7. PubMed ID: 28733204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
